Metastatic Breast Cancer With HER2 Positive

DBCOND0112973NeoplasmsSkin and Subcutaneous Tissue Diseases

Metastatic Breast Cancer With HER2 Positive is the indication for 3 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as
HER-2 Positive Metastatic Breast Cancer · Her2 Positive Metastatic Breast Cancer · HER2-positive Metastatic Breast Cancer · HER2 Positive Metastatic Breast Cancers · Metastatic HER2-Positive Breast Cancer
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT459391000124109UMLSC4721209

What you can answer from here — as of October 23, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
43Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Metastatic Breast Cancer With HER2 Positive share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In